About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Lilly Concocts Something New for Diabetics to Worry About: "Finger Health"

By David P. Hamilton | Apr 16, 2008

Diabetes finger prickThe drug industry has long thrived on creating “awareness” for new conditions for which it just happens to have a new treatment. With diabetes climbing the charts these days, it was probably only a matter of time before some enterprising marketer hit upon a way to get people clamoring for some related treatment they hadn’t previously known they needed.

That day is now here, courtesy of Eli Lilly and the medical-device startup Pelikan Technologies, who aim to alert diabetics that they have something new to worry about as they manage their chronic disease — “Finger Health.” And since it wouldn’t do to get people riled up without giving them something to buy or request from their doctors, it turns out that the new co-promotion campaign is getting underway just as Pelikan is launching a new type of finger-lancing device it says can eliminate much of the pain and “damage” diabetics experience while drawing regular droplets of blood for glucose testing.

Now, makers of glucose testers and associated lancets have been trying for years to minimize the discomfort of that blood-drawing, which is unquestionably an inconvenience for many and probably more than that for some. The Finger Health campaign, though, wants all diabetics to feel like they currently have to choose between “healthy fingers” and regular glucose testing, which is crucial to diabetic control. Pelikan’s Web site should give you a good sense of where that campaign is headed. One never-very-reassuring sign: Pelikan quotes from a “study” that supposedly suggests its lancet device causes less injury than others, but in an asterisked comment says only that the data is “on file at Pelikan Technologies.” Where it can’t do diabetics much good — but can’t also do Pelikan much harm, I suppose.

In any case, Lilly and Pelikan want to reassure diabetics that they no longer have to face that terrible choice, at least so long as they’re willing to shell out $200 for the Pelikan “computer-controlled” lancet device and its expensive needle cartridges ($15 for 100). Existing lancet pens, by the way, can be as inexpensive as $15 to $30, with the needles themselves running as little as $7 for 100.

But if you’re a diabetic, surely the extra expense is worth it in order to preserve your Finger Health, isn’t it? If you agree, there are some very caring people at Lilly and Pelikan who’d like to do their best to help.

Postscript: Lilly’s role in all this isn’t entirely clear to me. It may one day be interested in acquiring Pelikan, particularly if its technology might prove useful in making insulin injections themselves less painful, but for now Lilly makes billions selling insulin itself and appears likely to focus its “co-promotion” efforts on new types of insulin and injectors.

(Image via Flickr user Khürt, CC 2.0)

A 14-year veteran of the Wall Street Journal, David P. Hamilton is BNET's Industries editor. Prior to coming to BNET, David founded the LifeScience section of VentureBeat, a news site for the innovation and venture business.

BNET User Analysis

 
Reply to Story

BNET TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via Email or RSS

  •  
    1

    khurt@...

    04/19/08 | Report as spam

    Just what I need. NOT!

    My fingers may be dry and a little calloused in some places but I certainly do
    not consider them "damaged'. The "research" time spent on this condition could
    be better spent making the current glucose meters more accurate or the test
    strips less costly.

  •  
    2

    amytend

    05/16/08 | Report as spam

    Are you diabetic?

    Sorry David, but are you diabetic? I don't know about the long-term effects of "finger health," but I do know that the comfort issue is HUGE for me and HUGE for so many parents of children with Type 1 diabetes.

    Please see my review of the Pelikan Sun product at
    www.diabetesmine.com/2008/04/pelikan-challen.html

    Regards,

    AmyT
    www.diabetesmine.com

  •  
    3

    David P Hamilton

    06/17/08 | Report as spam

    Re: Are you diabetic?

    Amy: I'm not a diabetic, but two of my family members are. I certainly understand that finger pain and tenderness is an issue for some diabetics, but for many others it's less so. (I do get the point that children in particular may be inclined to do a lot less testing because of the "ouch" factor.)

    That said, it always makes me uneasy when big companies get into the business of promoting "disease awareness," because the effect is often to convince many people to ask their doctors for treatments they don't actually need. Admittedly, the stakes are relatively small here, since at most people are out the $200 it costs to get the Pelikan device. The principle is very much the same, though.

  •  
    4

    Diohdan

    07/10/08 | Report as spam

    RE: Lilly Concocts Something New for Diabetics to Worry About:

    The Pumpers: Better compliance for Insulin-dependent diabetic patients?

    With some diabetic patients, the hormone insulin may be absent, yet necessary for their survival. As I recall, a man named Pauescu developed the concept of insulin replacement, and discovered a method of using insulin secreted from pigs as a replacement method for humans, which was effective at that time. Legend has it that this concept originated in a dream this man had on a night soon before his idea became reality several decades ago. Yet presently, this hormone which is naturally produced by the pancreas normally has advanced as far as treatment goes for the diabetic patient through synthetic engineering, as this is needed for survival for some diabetic patients.
    Recently, the Denver Bronco???s quarterback, Jay Cutler, was recently diagnosed with diabetes, a disease that affects over 20 million people. As I recall, part of his treatment regimen involves what is called an insulin pump. They are approximately the size of a cell phone, and the users of such pumps are called, in the diabetic community, ???pumpers???. Developed primarily for type 1, or insulin-dependent diabetic patients, the pumps can be used by some type 2 diabetic patients if they have some dependence on insulin replacement, which has steadily increased over the years. The importance of the device is improved management of the disease, which can cause life-threatening consequences if the disease of diabetes is not controlled properly. By the way, he takes it off for games, practice, etc.
    The three elements The Pumps: A New Paradigm in diabetes management of an insulin pump include the pump itself and its components, such as the insulin tube for delivery of insulin, and a catheter that delivers basal and bolus doses, which are dependent on preset calculations. The amount of insulin is rapid acting to ensure maximal pharmacokinetics to create intensive insulinotherapy for required diabetes management. These insulin amounts are ultimately determined by the patient???s doctor, who is usually an Endocrinologist, including bolus doses determined by the patients glucose level calculated with their carbohydrate intake, also known as the meal- time dose. Furthermore, the amount of insulin delivered by these methods is quite small due to the nature of the medication being rapid acting.
    The makers of such pumps tend to partner with associations relevant to the disease of diabetes, as well as local chapters of such organizations as the ADA and Endocrinology societies that may exist, along with contacting diabetes educators frequently at different locations throughout the country. Unfortunately, there are few Endocrinologists in the United States, as it is not one of the more lucrative specialties of a doctor, so treatment of diabetes is dependent on many others who are not doctors, but patient care specialists regarding this disease.
    Competing companies are few, as there are approximately 5 insulin pumps in the market, with Medtronic having the largest share of 30 percent, as I understand. In addition, some pumps avoid the possibility of metabolic action therapy due to their dosing precision, in addition, there is at least one pump that has long acting lithium battery that averages about a 6 week lifespan, yet a pump user should have a battery replacement with them at all times. The personalized insulin and carbohydrate ratio provided by insulin pumps greatly reduces any incidence of such complications as hypoglycemia. Also, in addition to storing and recording glucose and carbohydrate values with a back up mechanisms, some insulin pumps have a low basal rate, which I understand is an advantage as well. Regardless, and in my opinion, the ultimate advantages of insulin pumps exist with all that are available to patients presently.
    The cartridges of the insulin pumps hold a large number of units of insulin, which is an additional benefit. Further benefits include the fact that the pumps are convenient and reliable- especially if damage is avoided to the pump. Most importantly, the personal service provided to the patients by the caregivers of existing diabetic teams in health care facilities from hospitals to health care centers dedicated to the disease of diabetes ensures proper management of their disease, much to the benefit of those who have diabetes.
    The market growth of insulin pumps is anticipated at over 10 percent a year, as only 20 percent of type 1 diabetic patients have utilized these pumps out of over a million type 1 diabetics in the United States. The market is speculated to be greater than one billion dollars and is expected to increase due to speculated growth of the Insulin pump market. Many believe this therapy is superior in comparison with previous treatment options available to diabetic patients, along with being less cumbersome for these patients. Because of this, there is decreased mortality along with increased quality of life for diabetics, as they are assured of better control of their disease in this rather convenient way. This has been proven by better A1C blood tests and glycemic control of diabetic patients.
    The steady dosing maintains the patient???s metabolic requirements and decreases long term consequences associated with diabetics. It has also been proven that insulin pumps result in fewer hospitalizations, ER visits, and episodes of hypoglycemia due to the excellent control provided by the insulin pumps while providing the necessary intensive therapy for their disease state. The fast acting insulin used in these pumps is created through genetic engineering, I believe. In addition, patients are encouraged to check their blood sugar greater than three times a day while on the insulin pump. So this system is both friendly to the user and is clearly a very convenient form of treatment for them. The A1C test, by the way, is a blood test that reflects the diabetic patient???s average blood sugar over a period of a few months.
    Those who may be interested in insulin pumps will include those described already, along with hospitals, long term care facilities, home health care agencies, pediatricians, and possibly dialysis clinics, to name a few. Most likely, those considered for insulin pumps will be diabetic patients that are unable to achieve compliance with their current treatment regimen, along with other benefits of insulin pumps stated so far.
    The diabetes team for a diabetic patient may include an Endocrinologist, a diabetes educator, a dietician, along with the insulin pump representative. Follow ups with this team may include review the progress of the insulin pump for the patient and how the patient is tolerating the treatment. Often, classes can be scheduled through an institution or center regarding insulin pump training a few times a month. Education and training about the insulin pump may include the following:


    1. Glycemic control importance and how to prevent and treat as needed
    2. Basal and bolus concepts and how they contribute to the treatment
    3. Pump basics and strategies. Negative effects stressed to pt. if their pump is not used properly.
    4. Importance of knowing blood sugar and why. Definitions of terms like A1C
    5. How to deliver a bolus dose after checking carbohydrate intake
    6. How to check the pump???s memory
    7. Troubleshooting, phone number access, and how to replace battery
    8. Emphasize the safety of the insulin pump if operated correctly
    9. Keeping a glucagon injection and spare battery with you



    Ultimately after training others, it is important that the patient acknowledges understanding of how the device works, as well as the consequences that may occur if directions are not followed that are ultimately determined by the patients doctor. And fortunately, doctors and others who treat diabetes now have a new tool or device to assure compliance and longevity of these patients.

    Innovation is a wonderful thing, such as what has been described. Control of such a large and devastating disease is of great importance, so there seems to be a much desired need for pumpers now and likely in the future. Especially for those patients who slack on following their prescribed treatment regimen. And this will have to do until relevant transplants to reverse diabetes become more frequent and less complicated.

    ???Death destroys a man. The idea of death saves him.??? --- E.M. Forster


    Dan Abshear

    Author??? note: What has been annotated is based upon information and belief

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement